Recombinant human endostatin enhances the radioresponse in esophageal squamous cell carcinoma by normalizing tumor vasculature and reducing hypoxia
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recombinant human endostatin enhances the radioresponse in esophageal squamous cell carcinoma by normalizing tumor vasculature and reducing hypoxia
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-09-28
DOI
10.1038/srep14503
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Longitudinal Evaluation of Partial Lung Irradiation in Mice by Using a Dedicated Image-Guided Small Animal Irradiator
- (2014) Patrick V. Granton et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Novel benzoxazines as inhibitors of angiogenesis
- (2014) Sara Al-Rawi et al. INVESTIGATIONAL NEW DRUGS
- Signaling pathways in the development of infantile hemangioma
- (2014) Yi Ji et al. Journal of Hematology & Oncology
- Endostar, a Modified Recombinant Human Endostatin, Suppresses Angiogenesis through Inhibition of Wnt/β-Catenin Signaling Pathway
- (2014) Xiaoming Xu et al. PLoS One
- Enhanced Radiation Sensitivity in HPV-Positive Head and Neck Cancer
- (2013) R. J. Kimple et al. CANCER RESEARCH
- A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma
- (2013) Chuanliang Cui et al. MOLECULAR THERAPY
- Nuclear PKM2 expression predicts poor prognosis in patients with esophageal squamous cell carcinoma
- (2013) Xuelin Zhang et al. PATHOLOGY RESEARCH AND PRACTICE
- Potential Reduction of Contralateral Second Breast-Cancer Risks by Prophylactic Mammary Irradiation: Validation in a Breast-Cancer-Prone Mouse Model
- (2013) Igor Shuryak et al. PLoS One
- Enhanced radioresponse with a novel recombinant human endostatin protein via tumor vasculature remodeling: Experimental and clinical evidence
- (2013) Mao-Bin Meng et al. RADIOTHERAPY AND ONCOLOGY
- Assessing the Radiation Response of Lung Cancer with Different Gene Mutations Using Genetically Engineered Mice
- (2013) Bradford A. Perez et al. Frontiers in Oncology
- Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy
- (2012) Weijing Sun Journal of Hematology & Oncology
- Can Determination of Circulating Endothelial Cells and Serum Caspase-Cleaved CK18 Predict for Response and Survival in Patients with Advanced Non–Small-Cell Lung Cancer Receiving Endostatin and Paclitaxel–Carboplatin Chemotherapy? A Retrospective Study
- (2012) Tian-Qing Chu et al. Journal of Thoracic Oncology
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Normalization of the Vasculature for Treatment of Cancer and Other Diseases
- (2011) Shom Goel et al. PHYSIOLOGICAL REVIEWS
- BMS-690514, a VEGFR and EGFR tyrosine kinase inhibitor, shows anti-tumoural activity on non-small-cell lung cancer xenografts and induces sequence-dependent synergistic effect with radiation
- (2010) Y Loriot et al. BRITISH JOURNAL OF CANCER
- Selective Killing of Tumor Neovasculature Paradoxically Improves Chemotherapy Delivery to Tumors
- (2010) F. E. Escorcia et al. CANCER RESEARCH
- Lenalidomide induced good clinical response in a patient with multiple relapsed and refractory Hodgkin's lymphoma
- (2010) Inga Mandac et al. Journal of Hematology & Oncology
- Endostatin inhibits tumour lymphangiogenesis and lymphatic metastasis via cell surface nucleolin on lymphangiogenic endothelial cells
- (2010) Wei Zhuo et al. JOURNAL OF PATHOLOGY
- N-terminal modification increases the stability of the recombinant human endostatinin vitro
- (2009) Li‑Ping Jiang et al. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
- Updates in Gastrointestinal Oncology – insights from the 2008 44th annual meeting of the American Society of Clinical Oncology
- (2009) Milind Javle et al. Journal of Hematology & Oncology
- A New Target for Tumor Therapy
- (2009) Rakesh K. Jain NEW ENGLAND JOURNAL OF MEDICINE
- Provascular strategy: Targeting functional adaptations of mature blood vessels in tumors to selectively influence the tumor vascular reactivity and improve cancer treatment
- (2008) Pierre Sonveaux RADIOTHERAPY AND ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search